Return to homepagePandemic Pact

A Variant-Proof COVID-19 Vaccine Strategy Based on Cryptic Epitopes

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA523092

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2026
    2029

  • Known Financial Commitments (USD)

    $1,159,252.32

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    Griffith University

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

We are developing a next-generation COVID-19 vaccine that targets hidden, conserved parts of the virus to provide strong, long-lasting protection. It uses an advanced delivery system to boost immune defences at the site of infection, helping stop both illness and transmission. This safer, more precise approach offers protection against current and future variants, reduces the need for boosters, and supports global pandemic preparedness.